Skip to main content

Gene Logic Garners NCI Contract for Preclinical Toxicology Studies

NEW YORK, April 8 (GenomeWeb News) - Gene Logic today said it has been tapped by the National Cancer Institute's Division of Cancer Treatment and Diagnosis to provide it with preclinical safety and pharmacology studies pertinent to its core cancer, AIDS, and AIDS-related illness research.


Terms of the deal call for Gene Logic to use its toxicogenomics platform to perform preclinical in vivo studies related to drug toxicity. The agreement, which is funded by NCI, the National Institutes of Health, and the Department of Health and Human Services, will pay Gene Logic up to $6.9 million over the next seven years.


This announcement follows several other government contracts awarded to Gene Logic over the last six months, including a multiyear contract with the National Institute of Allergy and Infectious Diseases, a one-year contract with the UniformedServicesUniversityof the Health Sciences, and an extension with the National Institute of Environmental Health Sciences.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.